The Commission should evaluate the functioning and effectiveness of this Regulation by four years and six months from the date of entry into force of this Regulation and every five years thereafter and should present a report to the European Parliament and to the Council. That report should analyse the evolution of foreign investments into the Union and assess the contribution of this Regulation to the economic security of the Union. It should also assess whether a modification of the common minimum scope of screening mechanisms is warranted, including as regards foreign investments into Union targets that manufacture or hold a marketing authorisation for critical medicines. In addition, that report should evaluate the risks linked to foreign investments in media services and how best to address them. It should also include an assessment of whether this Regulation should be amended. Where the report contains a proposal to amend this Regulation, the Commission should be able to append a legislative proposal thereto.
Recital 58, Regulation (EU) 2026/1386
In forcesince 17 Jun 2026